Trimester-specific reference intervals of hemostasis biomarkers for healthy pregnancy

References

• Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–168. doi: 10.1016/s1521-6926(03)00021-5.
   PubMed Web of Science ®Google Scholar
• James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326–331. doi: 10.1161/ATVBAHA.109.184127.
   PubMed Web of Science ®Google Scholar
• Joly B, Barbay V, Borg JY, et al. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies. Thromb Res. 2013;132(3):386–391. doi: 10.1016/j.thromres.2013.07.022.
   PubMed Web of Science ®Google Scholar
• Hedengran KK, Andersen MR, Stender S, et al. Large D-dimer fluctuation in normal pregnancy: a longitudinal cohort study of 4,117 samples from 714 healthy Danish women. Obstet Gynecol Int. 2016;2016:3561675. doi: 10.1155/2016/3561675.
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Ajzner E, Rogic D, et al. Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thromb Res. 2016;142:1–7. doi: 10.1016/j.thromres.2016.04.001.
   PubMed Web of Science ®Google Scholar
• McLean KC, James AH. Diagnosis and management of VTE in pregnancy. Clin Obstet Gynecol. 2018;61(2):206–218. doi: 10.1097/GRF.0000000000000354.
   PubMed Web of Science ®Google Scholar
• Sekiya A, Hayashi T, Kadohira Y, et al. Thrombosis prediction based on reference ranges of coagulation-related markers in different stages of pregnancy. Clin Appl Thromb Hemost. 2017;23(7):844–850. 15. doi: 10.1177/1076029616673732.
   PubMed Web of Science ®Google Scholar
• Onishi H, Kaniyu K, Iwashita M, et al. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy. Ann Clin Biochem. 2007;44(Pt 5):449–454. doi: 10.1258/000456307781646076.
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Petersen PH, Bjørge L, et al. Concentration of fibrin monomer in pregnancy and during the postpartum period. Ann Clin Biochem. 2019;56(6):692–700. doi: 10.1177/0004563219869732.
   PubMed Web of Science ®Google Scholar
• Refaai MA, Riley P, Mardovina T, et al. The clinical significance of fibrin monomers. Thromb Haemost. 2018;118(11):1856–1866. doi: 10.1055/s-0038-1673684.
   PubMed Web of Science ®Google Scholar
• Mei H, Jiang Y, Luo L, et al. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: a multi-center prospective observational study. Thromb Res. 2019;173:20–26. doi: 10.1016/j.thromres.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhang J, Zheng Z-R, et al. Diagnostic and prognostic value of TAT, PIC, TM, and t-PAIC in malignant tumor patients with venous thrombosis. Clin Appl Thromb Hemost. 2020;26:107602962097104. doi: 10.1177/1076029620971041.
   Web of Science ®Google Scholar
• Iba T, Thachil J. Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis. J Intensive Care. 2017;5:56. doi: 10.1186/s40560-017-0250-z.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Hamada Y, Ohkura T. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia. Int J Gynaecol Obstet. 2003;82(2):213–216. doi: 10.1016/s0020-7292(03)00193-0.
   PubMed Web of Science ®Google Scholar
• Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy. 2012;2012:374047. doi: 10.1155/2012/374047.
   PubMedGoogle Scholar
• Ilkhchoui Y, Szabo EE, Gerstein NS, et al. Cerebral venous thrombosis complicating severe preeclampsia in the postpartum period: a diagnostic challenge. J Clin Anesth. 2014;26(2):143–146. doi: 10.1016/j.jclinane.2013.11.007.
   PubMed Web of Science ®Google Scholar
• Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese society on thrombosis and hemostasis. Thromb J. 2016;14:42.
   PubMedGoogle Scholar
• Kuryliszyn-Moskal A, Zarzycki W, Dubicki A, et al. Clinical usefulness of videocapillaroscopy and selected endothelial cell activation markers in people with type 1 diabetes mellitus complicated by microangiopathy. Adv Med Sci. 2017;62(2):368–373. doi: 10.1016/j.advms.2016.11.007.
   PubMed Web of Science ®Google Scholar
• Tipoe TL, Wu WKK, Chung L, et al. Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality outcomes: a systematic review and meta-analysis. Front Immunol. 2018;9:1218. doi: 10.3389/fimmu.2018.01218.
   PubMed Web of Science ®Google Scholar
• Fowler AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261–1270. doi: 10.1001/jama.2019.11825.
   PubMed Web of Science ®Google Scholar
• Ito T, Thachil J, Asakura H, et al. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential. Crit Care. 2019;23(1):280. doi: 10.1186/s13054-019-2552-0.
   PubMed Web of Science ®Google Scholar
• Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. Int J Hematol. 2016;103(3):253–261. doi: 10.1007/s12185-015-1904-z.
   PubMed Web of Science ®Google Scholar
• Wu YF, Qiao Y, Zhang YM, et al. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women. J Obstet Gynaecol Res. 2021;47(1):368–374. doi: 10.1111/jog.14536.
   PubMed Web of Science ®Google Scholar
• Boyd JC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guidelines. 3rd Ed CLSI Document C28-A3c. 2010;28(3):15.
   Google Scholar
• Cui C, Yang S, Zhang J, et al. Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy. Thromb Res. 2017;156:82–86. doi: 10.1016/j.thromres.2017.05.021.
   PubMed Web of Science ®Google Scholar
• Haire G, Egan K, Parmar K, et al. Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: association with disease severity. Eur J Obstet Gynecol Reprod Biol. 2019;241:19–23. 26. doi: 10.1016/j.ejogrb.2019.07.035.
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Petersen PH, Røraas T, et al. Estimates of within-subject biological variation of protein C, antithrombin, protein S free, protein S activity, and activated protein C resistance in pregnant women. Clin Chem. 2017;63(4):898–907. doi: 10.1373/clinchem.2016.265900.
   PubMed Web of Science ®Google Scholar
• Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17–24. doi: 10.1016/j.blre.2014.09.003.
   PubMed Web of Science ®Google Scholar
• Erez O. Disseminated intravascular coagulation in pregnancy: new insights. Thrombosis Update. 2022;6:100083. doi: 10.1016/j.tru.2021.100083.
   Google Scholar
• Edelstam G, Löwbeer C, Kral G, et al. New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy. Scand J Clin Lab Invest. 2001;61(8):583–592. doi: 10.1080/003655101753267937.
   PubMed Web of Science ®Google Scholar
• O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17(3):385–396. doi: 10.1016/s1521-6934(03)00019-1.
   PubMed Web of Science ®Google Scholar